| Literature DB >> 27777976 |
Lisa R Young1,2,3, Peter M Gulleman1, Chelsi W Short1, Harikrishna Tanjore2, Taylor Sherrill2, Aidong Qi1, Andrew P McBride1, Rinat Zaynagetdinov2, John T Benjamin4, William E Lawson2, Sergey V Novitskiy2, Timothy S Blackwell2,3,5.
Abstract
Alveolar epithelial cell (AEC) dysfunction underlies the pathogenesis of pulmonary fibrosis in Hermansky-Pudlak syndrome (HPS) and other genetic syndromes associated with interstitial lung disease; however, mechanisms linking AEC dysfunction and fibrotic remodeling are incompletely understood. Since increased macrophage recruitment precedes pulmonary fibrosis in HPS, we investigated whether crosstalk between AECs and macrophages determines fibrotic susceptibility. We found that AECs from HPS mice produce excessive MCP-1, which was associated with increased macrophages in the lungs of unchallenged HPS mice. Blocking MCP-1/CCR2 signaling in HPS mice with genetic deficiency of CCR2 or targeted deletion of MCP-1 in AECs normalized macrophage recruitment, decreased AEC apoptosis, and reduced lung fibrosis in these mice following treatment with low-dose bleomycin. We observed increased TGF-β production by HPS macrophages, which was eliminated by CCR2 deletion. Selective deletion of TGF-β in myeloid cells or of TGF-β signaling in AECs through deletion of TGFBR2 protected HPS mice from AEC apoptosis and bleomycin-induced fibrosis. Together, these data reveal a feedback loop in which increased MCP-1 production by dysfunctional AECs results in recruitment and activation of lung macrophages that produce TGF-β, thus amplifying the fibrotic cascade through AEC apoptosis and stimulation of fibrotic remodeling.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27777976 PMCID: PMC5070955 DOI: 10.1172/jci.insight.88947
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708